SCTX

SCRIBE THERAPEUTICS INC

• Seeking Alpha·1d ago

  U.S. IPO Weekly Recap: CRISPR Biotech Pops 44% As More Names Join The IPO Pipeline

• Reuters·1d ago

  BUZZ-Scribe Therapeutics surges in New York debut after upsized $128.7 million IPO

• Reuters·1d ago

  BUZZ-U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty

• Seeking Alpha·1d ago

  Eli Lilly and Sanofi-backed Scribe surges in public debut

• TipRanks·1d ago

  Scribe Therapeutics opens at $25, IPO priced at $15 per share

• Reuters·1d ago

  BUZZ-U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor

• TipRanks·1d ago

  Scribe Therapeutics indicated to open at $25, IPO priced at $15 per share

• TipRanks·1d ago

  Scribe Therapeutics indicated to open at $29.20, IPO priced at $15 per share

• Reuters·1d ago

  BUZZ-Scribe Therapeutics set for New York debut after upsized $128.7 million IPO

• TipRanks·1d ago

  Scribe Therapeutics 8.58M share IPO priced at $15.00

• Dow Jones·1d ago

  Scribe Therapeutics Upsized IPO Priced at High End of Views

• Reuters·2d ago

  NASDAQ TRADE HALT <SCTX.O> REASON NOT AVAILABLE AT 04:00 AM

• NASDAQ·2d ago

  Scribe Therapeutics Sets IPO Of 8.58 Mln Shares At $15/Shr; Enters Private Placement With Sanofi

• Seeking Alpha·2d ago

  Scribe Therapeutics prices upsized IPO at $15/share

• Seeking Alpha·2d ago

  Eli Lilly-backed Scribe Therapeutics raises $128.7M in upsized IPO; set to trade on Nasdaq